Answer
Hepatitis B screening is recommended for all patients before starting Sofosbuvir/Velpatasvir/Voxilaprevir Gilead because HBV reactivation, sometimes fatal, has been reported during or after direct-acting antiviral treatment.
Sources for this answer
- Sofosbuvir/Velpatasvir/Voxilaprevir Gilead 400/100/100 mg Film-coated tabletGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 18Document updated
Sources checked